Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02917083
Title CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Baylor College of Medicine
Indications

Hodgkin's lymphoma

non-Hodgkin lymphoma

Therapies

ATLCAR.CD30 cells + Cyclophosphamide + Fludarabine

Age Groups: senior | adult | child
Covered Countries USA


No variant requirements are available.